Published in Clin Exp Immunol on November 01, 1998
Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment. J Clin Immunol (2001) 0.95
Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity. Infect Immun (2010) 0.95
Regulation of the expression of Fc gamma receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin Exp Immunol (1999) 0.84
Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80
Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway. Clin Exp Immunol (2002) 0.80
Allergen-specific IgG as a mediator of allergy inhibition: lessons from mother to child. Hum Vaccin Immunother (2016) 0.77
Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol (1995) 10.65
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol (1991) 6.30
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16
Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med (1993) 5.71
Cloning and expression of murine IL-12. J Immunol (1992) 4.92
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet (1981) 4.39
Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet (1993) 4.06
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med (1996) 3.82
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76
High-dose intravenous gammaglobulin for Kawasaki disease. Lancet (1984) 3.10
Manipulating the immune system with immune globulin. N Engl J Med (1992) 2.75
Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J Immunol (1994) 2.68
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect Immun (1994) 2.39
Effects of IL-12 on the response and susceptibility to experimental viral infections. J Immunol (1994) 2.31
Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo. Int Immunol (1994) 2.31
Interleukin-12. J Leukoc Biol (1994) 2.22
Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol (1982) 2.22
Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med (1994) 2.00
Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol (1990) 1.94
Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol (1995) 1.80
Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest (1993) 1.51
Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol (1986) 1.50
Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci U S A (1991) 1.46
Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. J Clin Invest (1987) 1.45
Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr Infect Dis (1983) 1.40
LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol (1996) 1.40
Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child (1995) 1.34
Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol (1996) 1.32
Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol (1998) 1.32
Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol (1996) 1.32
TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol (1994) 1.29
Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev (1994) 1.17
Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology (1993) 1.01
Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology (1997) 0.96
Purification and characterization of streptococcal erythrogenic toxin type A produced by Streptococcus pyogenes strain NY-5 cultured in the synthetic medium NCTC-135. Comparison with the dialyzed medium (TP medium)-derived toxin. Microbiol Immunol (1989) 0.91
Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: results in 73 patients. Am J Hematol (1993) 0.91
Interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: cytokine regulation and effect of NK cells. Infect Immun (1997) 0.89
Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur J Immunol (1994) 0.88
Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin. Clin Exp Immunol (1996) 0.84
Transfected murine cells expressing HLA class II can be used to generate alloreactive human T cell clones. J Immunol Methods (1994) 0.77
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science (2001) 8.31
TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest (2000) 5.78
Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet (1995) 5.03
Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res (1999) 4.68
Electrogenic Na-Ca exchange in retinal rod outer segment. Nature (1984) 3.23
Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem (2000) 2.80
Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation (1996) 2.79
Light-induced reduction of cytoplasmic free calcium in retinal rod outer segment. Nature (1985) 2.79
Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol (1999) 2.77
Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol (2001) 2.49
A new murine model of accelerated senescence. Mech Ageing Dev (1981) 2.40
Light-suppressible, cyclic GMP-sensitive conductance in the plasma membrane of a truncated rod outer segment. Nature (1985) 2.31
Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem (1999) 2.13
Cation selectivity of light-sensitive conductance in retinal rods. Nature (1984) 2.09
Purification and characterization of human NTH1, a homolog of Escherichia coli endonuclease III. Direct identification of Lys-212 as the active nucleophilic residue. J Biol Chem (1998) 2.06
The appearance of T cells bearing self-reactive T cell receptor in the livers of mice injected with bacteria. J Exp Med (1991) 1.99
Details of an isolation method for hepatic lymphocytes in mice. J Immunol Methods (1992) 1.97
Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation (1995) 1.92
Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. J Clin Pathol (2005) 1.90
The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses. Immunol Rev (2000) 1.89
Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes (1988) 1.86
Characterization of a stellate cell activation-associated protein (STAP) with peroxidase activity found in rat hepatic stellate cells. J Biol Chem (2001) 1.85
Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J Exp Med (1990) 1.84
Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer. J Clin Oncol (1999) 1.84
Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol (1997) 1.83
Cytotoxic NK1.1 Ag+ alpha beta T cells with intermediate TCR induced in the liver of mice by IL-12. J Immunol (1995) 1.80
Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology (2000) 1.71
Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem (1994) 1.70
Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology (1998) 1.70
Expression of ClpB, an analog of the ATP-dependent protease regulatory subunit in Escherichia coli, is controlled by a heat shock sigma factor (sigma 32). J Bacteriol (1991) 1.61
The cGMP-phosphodiesterase and its contribution to sensitivity regulation in retinal rods. J Gen Physiol (1995) 1.59
Age-related adipose tissue mRNA expression of ADD1/SREBP1, PPARgamma, lipoprotein lipase, and GLUT4 glucose transporter in rhesus monkeys. J Gerontol A Biol Sci Med Sci (1999) 1.56
PCR detection of distal Yp sequences in an XX true hermaphrodite. Am J Med Genet (1991) 1.54
Characterization of guanylate cyclase activity in single retinal rod outer segments. J Gen Physiol (1995) 1.53
Accuracy of suture placement. Br J Surg (1987) 1.51
Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation (1995) 1.51
Brain metastasis of Merkel cell carcinoma. Case report and review of the literature. Neurosurg Rev (1999) 1.51
Stilbazolium-MPS3 Nanocomposites with Large Second-Order Optical Nonlinearity and Permanent Magnetization. Science (1994) 1.51
Calcium feedback and sensitivity regulation in primate rods. J Gen Physiol (1991) 1.50
Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J Immunol (1992) 1.50
Neuroendoscopic approach to tectal tumors: a consecutive series. J Neurosurg (1999) 1.48
Ontogeny and development of extrathymic T cells in mouse liver. Immunology (1992) 1.47
Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice. J Immunol (2001) 1.46
Stable expression in rat glioma cells of sense and antisense nucleic acids to a human multifunctional DNA repair enzyme, APEX nuclease. Mutat Res (1994) 1.42
Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med (1989) 1.42
LPS induces NK1.1+ alpha beta T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol (1996) 1.40
Clinicopathological characterization of prion: a novel marker of activated human hepatic stellate cells. J Hepatol (2000) 1.39
Estrogen administration activates extrathymic T cell differentiation in the liver. J Exp Med (1992) 1.38
Efficacy of a new hemostatic device, Adapty , after transradial coronary angiography and intervention. J Invasive Cardiol (2000) 1.38
Functional anatomy of GO/NO-GO discrimination and response selection--a PET study in man. Brain Res (1996) 1.38
Assessment of usefulness of endobronchial ultrasonography in determination of depth of tracheobronchial tumor invasion. Chest (1999) 1.37
Grading score system: a method for evaluation of the degree of senescence in senescence accelerated mouse (SAM). Mech Ageing Dev (1984) 1.36
Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci (1996) 1.35
Proteome analysis of rat hepatic stellate cells. Hepatology (2000) 1.34
Cyclic GMP diffusion coefficient in rod photoreceptor outer segments. Biophys J (1995) 1.33
Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1998) 1.32
Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J Immunol (1996) 1.32
Involvement of NK1+ T cells and their IFN-gamma production in the generalized Shwartzman reaction. J Immunol (1998) 1.32
Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol (1996) 1.32
Simulation of intracellular Ca2+ oscillation in a sympathetic neurone. J Theor Biol (1981) 1.30
Activation of protein kinase B/Akt is sufficient to repress the glucocorticoid and cAMP induction of phosphoenolpyruvate carboxykinase gene. J Biol Chem (1998) 1.30
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases. Cancer Res (1991) 1.29
Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res (1991) 1.29
Anti-oxidative properties of fluvastatin, an HMG-CoA reductase inhibitor, contribute to prevention of atherosclerosis in cholesterol-fed rabbits. Atherosclerosis (2001) 1.28
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma. Br J Cancer (2009) 1.28
A new method of paired thyrotropin assay as a screening test for neonatal hypothyroidism. J Clin Endocrinol Metab (1978) 1.27
Induction of human TCR gamma delta + and TCR gamma delta-CD2+CD3- double negative lymphocytes by bacterial stimulation. Int Immunol (1990) 1.26
Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Immunology (2001) 1.25
Light adaptation in cat retinal rods. Science (1989) 1.25
Observation of magnetic excitations of Skyrmion crystal in a helimagnetic insulator Cu2OSeO3. Phys Rev Lett (2012) 1.24
Predominant appearance of gamma/delta T lymphocytes in the liver of mice after birth. Eur J Immunol (1991) 1.24
Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol (1997) 1.24
Regional cerebral blood flow changes of cortical motor areas and prefrontal areas in humans related to ipsilateral and contralateral hand movement. Brain Res (1993) 1.24
Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension (1999) 1.23
Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol (1994) 1.22
Anatomic variations of the radial artery in patients undergoing transradial coronary intervention. Catheter Cardiovasc Interv (2000) 1.21
Two-person technique for fiberscope-aided tracheal intubation in a patient with a long and narrow retropharyngeal air space. Anesth Analg (2001) 1.21
c-kit+ stem cells and thymocyte precursors in the livers of adult mice. J Exp Med (1996) 1.21
Nitric oxide modulates Ca(2+) channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol (2001) 1.20
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis. Int J Radiat Oncol Biol Phys (2001) 1.20
Far field scattering pattern of differently structured butterfly scales. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2007) 1.20
Purification and properties of Aspergillus niger beta-glucosidase. Eur J Biochem (1992) 1.20
Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation (1999) 1.20
Cloning and sequencing of a 36-kb region of the Bacillus subtilis genome between the gnt and iol operons. DNA Res (1995) 1.20
Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun (1995) 1.19
Enhanced second harmonic generation on passing from a mono- to a dicopper(II) bis(salicylaldiminato) schiff base complex. Inorg Chem (2001) 1.19
Macrophage- and neutrophil-dominant arthritis in human IL-1 alpha transgenic mice. J Clin Invest (2001) 1.19
Induction of human beta-defensin-2 mRNA expression by Helicobacter pylori in human gastric cell line MKN45 cells on cag pathogenicity island. Biochem Biophys Res Commun (1999) 1.18
Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials. Br J Cancer (2009) 1.17
Targeted disruption of cadherin-11 leads to a reduction in bone density in calvaria and long bone metaphyses. J Bone Miner Res (2001) 1.16